Lupin Ltd.
Snapshot View

743.00 -3.30 ▼-0.4%

27 January 2023, 04:01:00 PM
Volume: 9,708

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lupin.com
Market Cap 33,760.86 Cr.
Enterprise Value(EV) 36,904.38 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.50 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 495.63 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 260.82 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.85 Calculated using Price: 743.00
Dividend Yield 0.54 Period Ending 2022-03
No. of Shares Subscribed 45.49 Cr. 454,875,499 Shares
FaceValue 2
Company Profile
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. Lupin is recognised as one of the world's largest manufacturers of Tuberculosis drugs. The company have significant market share across multiple therapy areas such as Cardiovascular (prils and statins), Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro Intestinal (GI), Anti-Infective (AI) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). To add to this, the company has proud to maintain over the years its global leadership positions in other therapy areas such as Anti-TB and Cephalosporin.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.44%
1 Week
-1.38%
1 Month
+0.16%
3 Month
+5.68%
6 Month
+16.05%
1 Year
-16.34%
2 Year
-30.84%
5 Year
-21.83%
10 Year
+23.94%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 30.89 31.09 22.80 20.98 1.91 4.55 -2.12 9.46 -11.79
Return on Capital Employed (%) 40.97 40.30 24.38 18.53 3.54 8.45 6.02 9.70 -7.11
Return on Assets (%) 19.70 21.08 12.82 10.57 0.99 2.32 -1.05 5.09 -6.70

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6,932 8,874 11,163 13,498 13,577 13,742 12,537 13,803 12,153 11,864
Non Curr. Liab. 507 426 6,032 6,447 6,876 7,296 3,003 1,136 1,153 1,103
Curr. Liab. 2,630 3,729 5,061 6,121 5,096 6,130 9,225 8,436 8,276 8,488
Minority Int. 67 24 32 35 40 47 44 55 69 60
Equity & Liab. 10,135 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651 21,515
Non Curr. Assets 4,035 5,221 12,402 14,147 13,379 13,362 9,396 9,444 9,194 9,668
Curr. Assets 6,100 7,832 9,887 11,953 12,210 13,854 15,413 13,986 12,458 11,847
Misc. Exp. not W/O
Total Assets 10,135 13,054 22,289 26,100 25,589 27,215 24,810 23,430 21,651 21,515

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 11,287 12,770 14,139 17,494 15,804 16,751 16,837 15,163 16,405 15,933
Other Income 116 240 185 107 150 333 484 136 214 180
Total Income 11,403 13,010 14,324 17,601 15,955 17,084 17,320 15,299 16,619 16,113
Total Expenditure -8,284 -9,150 -10,454 -13,001 -12,657 -14,082 -14,362 -12,596 -16,190 -14,720
PBIDT 3,119 3,859 3,871 4,600 3,298 3,002 2,958 2,703 429 1,393
Interest -27 -10 -59 -153 -204 -302 -363 -141 -143 -173
Depreciation -261 -435 -487 -912 -1,086 -846 -970 -887 -1,659 -927
Taxation -962 -970 -1,059 -979 -288 -902 -1,147 -449 -137 -209
Exceptional Items -1,464 -340 -752
PAT 1,870 2,444 2,265 2,556 255 612 -274 1,227 -1,510 85
Minority Interest -33 -41 -9 -7 -7 -11 -19 -17
Share Associate 5 8 4 -5 4 1 0 0
Other Related Items
Consolidated Net Profit 1,836 2,403 2,261 2,557 251 607 -269 1,217 -1,528 68
Adjusted EPS 41 53 50 57 6 13 -6 27 -34 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,251 2,004 2,733 -382 4,114 1,751 1,666 1,469 1,822 367
Cash Fr. Inv. -522 -859 -1,055 -6,962 -2,527 470 -3,282 1,107 -1,240 1,292
Cash Fr. Finan. -663 -857 -197 5,836 433 -1,492 744 -891 -1,885 -1,572
Net Change 66 288 1,482 -1,508 2,019 729 -872 1,685 -1,303 87
Cash & Cash Eqvt 311 607 2,108 780 2,799 1,416 544 2,229 926 1,013

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 46.88 46.86 46.84 46.83 46.81 46.78 47.10 47.11 47.10
Public 53.12 53.14 53.16 53.17 53.19 53.22 52.90 52.89 52.90
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 25 Jan 2023
Board Meeting Intimation for Considering And Taking On Record Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2022.
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve unaudited financial results of the Company for the quarter and nine-months ended December 31 2022.
Tue, 24 Jan 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin Launches LYFE its Digital Therapeutic Solution for Holistic Heart Care.
Fri, 20 Jan 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Disclosure pursuant to allotment of 114899 shares under ESOP.

Technical Scans View Details >>

Fri, 27 Jan 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Lupin Ltd.

What is Lupin share price?

Can I buy Lupin shares now?

What is the Dividend Yield of Lupin?

What is the Market Cap of Lupin?

What are the key metrics to analyse Lupin?

What is the 52 Week High and Low of Lupin?

What is the trend of Lupin share price?